BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 28230866)

  • 1. Oridonin induces autophagy via inhibition of glucose metabolism in p53-mutated colorectal cancer cells.
    Yao Z; Xie F; Li M; Liang Z; Xu W; Yang J; Liu C; Li H; Zhou H; Qu LH
    Cell Death Dis; 2017 Feb; 8(2):e2633. PubMed ID: 28230866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triggering Fbw7-mediated proteasomal degradation of c-Myc by oridonin induces cell growth inhibition and apoptosis.
    Huang HL; Weng HY; Wang LQ; Yu CH; Huang QJ; Zhao PP; Wen JZ; Zhou H; Qu LH
    Mol Cancer Ther; 2012 May; 11(5):1155-65. PubMed ID: 22389469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ROS/JNK/c-Jun axis is involved in oridonin-induced caspase-dependent apoptosis in human colorectal cancer cells.
    Zhang D; Zhou Q; Huang D; He L; Zhang H; Hu B; Peng H; Ren D
    Biochem Biophys Res Commun; 2019 Jun; 513(3):594-601. PubMed ID: 30981511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oridonin inhibits hypoxia-induced epithelial-mesenchymal transition and cell migration by the hypoxia-inducible factor-1α/matrix metallopeptidase-9 signal pathway in gallbladder cancer.
    Chen K; Ye J; Qi L; Liao Y; Li R; Song S; Zhou C; Feng R; Zhai W
    Anticancer Drugs; 2019 Oct; 30(9):925-932. PubMed ID: 31517732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of c-Met promoted apoptosis, autophagy and loss of the mitochondrial transmembrane potential in oridonin-induced A549 lung cancer cells.
    Liu Y; Liu JH; Chai K; Tashiro S; Onodera S; Ikejima T
    J Pharm Pharmacol; 2013 Nov; 65(11):1622-42. PubMed ID: 24102522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oridonin inhibits mTOR signaling and the growth of lung cancer tumors.
    Wang YY; Lv YF; Lu L; Cai L
    Anticancer Drugs; 2014 Nov; 25(10):1192-200. PubMed ID: 25075795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oridonin phosphate-induced autophagy effectively enhances cell apoptosis of human breast cancer cells.
    Li Y; Wang Y; Wang S; Gao Y; Zhang X; Lu C
    Med Oncol; 2015 Jan; 32(1):365. PubMed ID: 25491140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, and evaluation of in vitro and in vivo anticancer activity of 14-substituted oridonin analogs: A novel and potent cell cycle arrest and apoptosis inducer through the p53-MDM2 pathway.
    Shen QK; Deng H; Wang SB; Tian YS; Quan ZS
    Eur J Med Chem; 2019 Jul; 173():15-31. PubMed ID: 30981113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oridonin triggers apoptosis in colorectal carcinoma cells and suppression of microRNA-32 expression augments oridonin-mediated apoptotic effects.
    Yang J; Jiang H; Wang C; Yang B; Zhao L; Hu D; Qiu G; Dong X; Xiao B
    Biomed Pharmacother; 2015 May; 72():125-34. PubMed ID: 26054686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DT-13 inhibited the proliferation of colorectal cancer via glycolytic metabolism and AMPK/mTOR signaling pathway.
    Wei X; Mao T; Li S; He J; Hou X; Li H; Zhan M; Yang X; Li R; Xiao J; Yuan S; Sun L
    Phytomedicine; 2019 Feb; 54():120-131. PubMed ID: 30668361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fangchinoline exerts anticancer effects on colorectal cancer by inducing autophagy via regulation AMPK/mTOR/ULK1 pathway.
    Xiang X; Tian Y; Hu J; Xiong R; Bautista M; Deng L; Yue Q; Li Y; Kuang W; Li J; Liu K; Yu C; Feng G
    Biochem Pharmacol; 2021 Apr; 186():114475. PubMed ID: 33609560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor activity of oridonin on SNU-5 subcutaneous xenograft model via regulation of c-Met pathway.
    Liu H; Qian C; Shen Z
    Tumour Biol; 2014 Sep; 35(9):9139-46. PubMed ID: 24916572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic anticancer effects of combined γ-tocotrienol and oridonin treatment is associated with the induction of autophagy.
    Tiwari RV; Parajuli P; Sylvester PW
    Mol Cell Biochem; 2015 Oct; 408(1-2):123-37. PubMed ID: 26112904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anticancer effect of oridonin is mediated by fatty acid synthase suppression in human colorectal cancer cells.
    Kwan HY; Yang Z; Fong WF; Hu YM; Yu ZL; Hsiao WL
    J Gastroenterol; 2013 Feb; 48(2):182-92. PubMed ID: 22722903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oridonin induces apoptosis and senescence in colorectal cancer cells by increasing histone hyperacetylation and regulation of p16, p21, p27 and c-myc.
    Gao FH; Hu XH; Li W; Liu H; Zhang YJ; Guo ZY; Xu MH; Wang ST; Jiang B; Liu F; Zhao YZ; Fang Y; Chen FY; Wu YL
    BMC Cancer; 2010 Nov; 10():610. PubMed ID: 21054888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-kappab facilitates oridonin-induced apoptosis and autophagy in HT1080 cells through a p53-mediated pathway.
    Zhang Y; Wu Y; Wu D; Tashiro S; Onodera S; Ikejima T
    Arch Biochem Biophys; 2009 Sep; 489(1-2):25-33. PubMed ID: 19646415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oridonin inhibits tumor growth and metastasis through anti-angiogenesis by blocking the Notch signaling.
    Dong Y; Zhang T; Li J; Deng H; Song Y; Zhai D; Peng Y; Lu X; Liu M; Zhao Y; Yi Z
    PLoS One; 2014; 9(12):e113830. PubMed ID: 25485753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oridonin inhibits BxPC-3 cell growth through cell apoptosis.
    Xu B; Shen W; Liu X; Zhang T; Ren J; Fan Y; Xu J
    Acta Biochim Biophys Sin (Shanghai); 2015 Mar; 47(3):164-73. PubMed ID: 25651847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oridonin induces apoptosis and autophagy in murine fibrosarcoma L929 cells partly via NO-ERK-p53 positive-feedback loop signaling pathway.
    Ye YC; Wang HJ; Xu L; Liu WW; Liu BB; Tashiro S; Onodera S; Ikejima T
    Acta Pharmacol Sin; 2012 Aug; 33(8):1055-61. PubMed ID: 22842735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxyl radical (·OH) played a pivotal role in oridonin-induced apoptosis and autophagy in human epidermoid carcinoma A431 cells.
    Yu Y; Fan SM; Song JK; Tashiro S; Onodera S; Ikejima T
    Biol Pharm Bull; 2012; 35(12):2148-59. PubMed ID: 23207767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.